ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 1,468 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 1,468 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 1,468 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -16.7% | 1,468 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 1,468 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -25.0% | 1,468 | -6.4% | 0.00% | – |
| Q3 2017 | $8,000 | -95.5% | 1,568 | -95.4% | 0.00% | -100.0% |
| Q2 2017 | $179,000 | +2883.3% | 34,433 | +2245.6% | 0.01% | – |
| Q1 2017 | $6,000 | +20.0% | 1,468 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -37.5% | 1,468 | -40.5% | 0.00% | – |
| Q3 2016 | $8,000 | +100.0% | 2,468 | +68.1% | 0.00% | – |
| Q2 2016 | $4,000 | – | 1,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |